For The Better

The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs.

The iconic growth investor was a buyer of Reddit on its first day of trading.

Signet looks poised to return more cash to shareholders in the coming years.

This ascending fast-casual restaurant concept has rewarded investors in 2024, but can that trend continue over the long haul?

The online pet retailer’s high-growth days could be over.

Near-term headwinds are knocking down the stock, but analysts at Argus see a longer-term opportunity.

While it’s easy to automatically follow in the Oracle of Omaha’s footsteps, investors should think critically and independently.

GigaCloud Technology is a global business logistics company demonstrating excellent growth.

The pet retailer could expand profits even as revenue growth remains muted.

The big run-up since this time last year could be intimidating to some prospective investors.

On the heels of Palantir’s successful AIP Con event, Peter Thiel sold $178 million worth of the company’s stock.

These two adtech stocks have the ability to deliver monster returns.

This consumer lender’s stock is up a lot in the past year, but there’s one big reason I wouldn’t buy it today.

This industry leader should be on your investing radar.

The tobacco giant still looks like a high-yield trap.

Beyond its stunning product roadmap, Nvidia just played another card that could hurt its would-be rival.

Rivian is forecasting zero production growth in 2024.

The tech veteran recently closed its largest acquisition to date.

Investors are losing confidence in this one-time market darling.

Which is a better fit for your investing goals?